Literature DB >> 8234102

Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

R A Asherson1, S D Denburg, J A Denburg, R M Carbotte, N Futrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8234102      PMCID： PMC2399680          DOI： 10.1136/pgmj.69.814.602

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  87 in total

1.  CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

Authors:  E L DUBOIS; D L TUFFANELLI
Journal:  JAMA       Date:  1964-10-12       Impact factor: 56.272

2.  Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.

Authors:  R A Fields; W L Sibbitt; H Toubbeh; A D Bankhurst
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

3.  Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.

Authors:  S Minota; J B Winfield
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

Review 4.  Recent observations on central nervous system lupus erythematosus.

Authors:  D A Bennahum; R P Messner
Journal:  Semin Arthritis Rheum       Date:  1975-02       Impact factor: 5.532

5.  Nature of IgG anti-lymphocyte autoantibody-reactive molecules shed from activated T cells in systemic lupus erythematosus.

Authors:  S Minota; J B Winfield
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

6.  Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement.

Authors:  S Hirohata; T Miyamoto
Journal:  Arthritis Rheum       Date:  1990-05

7.  The pathogenesis of neuropsychiatric lupus.

Authors:  J A Denburg; P Temesvari
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

8.  Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients.

Authors:  T Hirano; H Hashimoto; Y Shiokawa; M Iwamori; Y Nagai; M Kasai; Y Ochiai; K Okumura
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

9.  Association between lupus psychosis and anti-ribosomal P protein antibodies.

Authors:  E Bonfa; S J Golombek; L D Kaufman; S Skelly; H Weissbach; N Brot; K B Elkon
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

10.  Cellular sources and effects of tumor necrosis factor-alpha on pituitary cells and in the central nervous system.

Authors:  P Ricciardi-Castagnoli; L Pirami; M Righi; P Sacerdote; V Locatelli; M Bianchi; M Sassano; P Valsasnini; S Shammah; A E Panerai
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691
View more
  4 in total

1.  Neuropsychiatric Symptoms in Lupus.

Authors:  Maria Gulinello; Jing Wen; Chaim Putterman
Journal:  Psychiatr Ann       Date:  2012-09

2.  Pseudotumour cerebri in SLE.

Authors:  D Horoshovski; H Amital; M Katz; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

3.  Characterization of systemic lupus erythematosus in patients in U.A.E.

Authors:  H M al-Attia; S George
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

Review 4.  The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.

Authors:  Maria Gulinello; Chaim Putterman
Journal:  J Biomed Biotechnol       Date:  2011-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.